ADT is frequently combined with radiation therapy for the treatment of men with intermediate- or high-risk prostate cancer. No evidence suggests that this treatment platform benefits patients with low- or favorable-risk disease.
Read MoreRace/ethnicity: African-American men and Caribbean men are more likely to develop prostate cancer compared to men of other races. African-American men are more than twice as likely to die of prostate cancer compared to Caucasian men. Prostate cancer occurs less often in Asian-American and Hispanic/Latino men than in non-Hispanic whites.
Read More
